Long COVID linked to increased risk for cardiac arrhythmias and coronary artery disease; increased risk for heart failure, peripheral artery disease seen in women only ...
ApoB goal optimal in 65% of probabilistic analyses at willingness-to-pay threshold of $120,000 per QALY gained.
The BRUIN CLL-322 trial evaluated the safety and efficacy of pirtobrutinib plus venetoclax and rituximab in previously treated CLL/SLL patients.
This antibody-drug conjugate targets a specific protein associated with poor prognosis in patients whose disease progressed after platinum-based chemotherapy.
STAT6 degradation is expected to provide a clinical benefit for patients with Type 2 inflammatory diseases, including asthma.
The contaminated products, distributed exclusively to physician offices, may increase the risk for infection, skin irritation, or delayed wound healing.
Despite the initiation of a phase 3 confirmatory trial, the FDA remains unsatisfied with the interpretability of phase 2 data for Replimune’s oncolytic immunotherapy.
HealthDay News — For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to ...
HealthDay News — Influenza vaccination may offer cardiovascular protection even when it does not prevent infection, according to a study published online April 2 in Eurosurveillance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results